RESUMEN
OBJECTIVES: Camostat mesilate is a drug that is being repurposed for new applications such as that against COVID-19 and prostate cancer. This induces a need for the development of an analytical method for the quantification of camostat and its metabolites in plasma samples. Camostat is, however, very unstable in whole blood and plasma due to its two ester bonds. The molecule is readily hydrolysed by esterases to 4-(4-guanidinobenzoyloxy)phenylacetic acid (GBPA) and further to 4-guanidinobenzoic acid (GBA). For reliable quantification of camostat, a technique is required that can instantly inhibit esterases when blood samples are collected. DESIGN AND METHODS: An ultra-high-performance liquid chromatography-tandem mass spectrometry method (UHPLC-ESI-MS/MS) using stable isotopically labelled analogues as internal standards was developed and validated. Different esterase inhibitors were tested for their ability to stop the hydrolysis of camostat ester bonds. RESULTS: Both diisopropylfluorophosphate (DFP) and paraoxon were discovered as efficient inhibitors of camostat metabolism at 10 mM concentrations. No significant changes in camostat and GBPA concentrations were observed in fluoride-citrate-DFP/paraoxon-preserved plasma after 24 h of storage at room temperature or 4 months of storage at -20 °C and -80 °C. The lower limits of quantification were 0.1 ng/mL for camostat and GBPA and 0.2 ng/mL for GBA. The mean true extraction recoveries were greater than 90%. The relative intra-laboratory reproducibility standard deviations were at a maximum of 8% at concentrations of 1-800 ng/mL. The trueness expressed as the relative bias of the test results was within ±3% at concentrations of 1-800 ng/mL. CONCLUSIONS: A methodology was developed that preserves camostat and GBPA in plasma samples and provides accurate and sensitive quantification of camostat, GBPA and GBA by UHPLC-MS/MS.
Asunto(s)
Recolección de Muestras de Sangre/métodos , Cromatografía Líquida de Alta Presión/métodos , Ésteres/sangre , Guanidinas/sangre , Espectrometría de Masas en Tándem/métodos , COVID-19/sangre , Inhibidores Enzimáticos/farmacología , Esterasas/antagonistas & inhibidores , Esterasas/metabolismo , Ésteres/metabolismo , Ésteres/farmacología , Guanidinas/farmacología , Humanos , Hidrólisis/efectos de los fármacos , Isoflurofato/química , Isoflurofato/farmacología , Paraoxon/sangre , Paraoxon/química , Paraoxon/farmacología , Reproducibilidad de los Resultados , SARS-CoV-2/aislamiento & purificación , Tratamiento Farmacológico de COVID-19RESUMEN
The purpose of the study was to examine the effects of astaxanthin (Asx) on paraoxonase (PON1) activities and oxidative stress status in soccer players. Forty soccer players were randomly assigned in a double-blind fashion to Asx and placebo (P) group. Blood samples were obtained before, 45 and 90 days after supplementation. PON1 activity was assessed by using two substrates: paraoxon and diazoxon. The oxidative stress biomarkers were also examined: total sulphydryl group content (-SH groups), thiobarbituric acid-reactive substances (TBARS), advanced oxidation protein products and redox balance. The significant interaction effect of supplementation and training (p < 0.05) on PON1 activity toward paraoxon was observed. The PON1 activity toward diazoxon increased in Asx group after 90 days (p < 0.01), while there was no significant difference in P group. SH groups content rose from pre- to post-supplementation period only in Asx group (supplementation and training, p < 0.05; training, p < 0.01). TBARS levels decreased after 45 days and increased after 90 days of regular soccer training in both groups (training, p < 0.001). Redox balance decreased significantly in response to the regular training, regardless of treatment group (training, p < 0.001). Asx supplementation might increase total SH groups content and improve PON1 activity through protection of free thiol groups against oxidative modification.
Asunto(s)
Antioxidantes/farmacología , Arildialquilfosfatasa/metabolismo , Atletas , Estrés Oxidativo/efectos de los fármacos , Adolescente , Antioxidantes/administración & dosificación , Arildialquilfosfatasa/genética , Biomarcadores/sangre , Biomarcadores/metabolismo , Composición Corporal , Suplementos Dietéticos , Método Doble Ciego , Humanos , Lípidos/sangre , Masculino , Compuestos Organofosforados/sangre , Oxidación-Reducción , Consumo de Oxígeno , Paraoxon/sangre , Polimorfismo Genético , Estudios Prospectivos , Fútbol , Sustancias Reactivas al Ácido Tiobarbitúrico/análisis , Xantófilas/administración & dosificación , Xantófilas/farmacologíaRESUMEN
RATIONALE: Esterase inhibitors are widely used to stabilize ester-containing drugs in biological matrices for quantitative liquid chromatography/tandem mass spectrometry (LC/MS/MS) assays. These co-existing inhibitors could cause matrix effects on bioanalysis and jeopardize the assay performance. We therefore developed an LC/MS/MS methodology to monitor the fate of inhibitors and evaluate their matrix effects, which is described in this study. METHODS: Human plasma containing 20 mM of diisopropylfluorophosphate (DFP), paraoxon, eserine, phenylmethylsulfonyl fluoride (PMSF) or 2-thenoyltrifluoroacetone (TTFA) was extracted by liquid-liquid extraction (LLE) and analyzed by an LC/MS/MS assay for BMS-068645 (a model drug) with additional pre-optimized selected reaction monitoring (SRM) transitions using positive/negative electrospray ionization (ESI) mode for each inhibitor. Hydrolytic products were characterized by product ion or neutral loss scan LC/MS/MS analysis. The matrix effect contribution from each inhibitor was evaluated by post-column infusion of BMS-068645. RESULTS: In the extracted samples by LLE, SRM chromatograms revealed the presence of paraoxon, eserine and TTFA with peak intensity of >2.50E08. Three DFP hydrolytic products, diisopropyl phosphate (DP), triisopropyl phosphate (TP) and DP dimer, and one PMSF hydrolytic product, phenymethanesulfonic acid (PMSA), were identified in the extracted samples. In post-column infusion profiles, ion suppression or enhancement was observed in the retention time regions of eserine (~10% suppression), paraoxon (~70% enhancement) and DP dimer (~20% suppression). CONCLUSIONS: The SRM transitions described here make it possible to directly monitor the inhibitors and their hydrolytic products. In combination with post-column infusion, this methodology provides a powerful tool to routinely monitor the matrix effects-causing inhibitors, so that their matrix effects on the bioanalysis can be evaluated and minimized.
Asunto(s)
Análisis Químico de la Sangre/métodos , Cromatografía Liquida/métodos , Inhibidores Enzimáticos/química , Esterasas/antagonistas & inhibidores , Espectrometría de Masas en Tándem/métodos , Alquinos/sangre , Alquinos/química , Análisis Químico de la Sangre/normas , Estabilidad de Medicamentos , Inhibidores Enzimáticos/sangre , Inhibidores Enzimáticos/metabolismo , Humanos , Hidrólisis , Isoflurofato/sangre , Isoflurofato/química , Isoflurofato/metabolismo , Modelos Químicos , Paraoxon/sangre , Paraoxon/química , Paraoxon/metabolismo , Fluoruro de Fenilmetilsulfonilo/sangre , Fluoruro de Fenilmetilsulfonilo/química , Fluoruro de Fenilmetilsulfonilo/metabolismo , Fisostigmina/sangre , Fisostigmina/química , Fisostigmina/metabolismo , Nucleósidos de Purina/sangre , Nucleósidos de Purina/química , Tenoiltrifluoroacetona/análisis , Tenoiltrifluoroacetona/química , Tenoiltrifluoroacetona/metabolismoRESUMEN
OBJECTIVE: The objective of the study was to determine whether an association exists between low paraoxonase 1 activity and dyslipidemia at midgestation and preterm birth. STUDY DESIGN: We conducted a case-control study of 30 women with preterm birth and 90 women with uncomplicated term deliveries. Maternal serum collected at 15-20 weeks was used to measure lipid concentrations and paraoxonase 1 activity using 2 substrates: paraoxon and phenylacetate (arylesterase activity). RESULTS: The groups did not differ with respect to maternal demographics. Paraoxonase 1 activity (paraoxon) was significantly lower in women delivering preterm compared with controls (12.9 +/- 6.1 vs 16.6 +/- 7.7 dA/min; P = .02). Arylesterase activity and serum lipid concentrations were similar between women with preterm birth and controls. CONCLUSION: Midgestation paraoxonase 1 activity is lower in women who later experience spontaneous preterm birth compared with women who have term deliveries. Prospective studies are needed to determine the significance of paraoxonase 1 in the pathogenesis of preterm birth.
Asunto(s)
Arildialquilfosfatasa/sangre , Nacimiento Prematuro/sangre , Adulto , Estudios de Casos y Controles , Femenino , Edad Gestacional , Humanos , Lípidos/sangre , Paraoxon/sangre , Fenilacetatos/sangre , Embarazo , Estudios RetrospectivosRESUMEN
BACKGROUND: Paraoxonase-1 (PON1) is an antioxidant enzyme that attenuates the production of the monocyte chemoattractant protein-1 (MCP-1) in vitro. Although oxidation and inflammation are closely related processes, the association between PON1 and MCP-1 has not been completely characterised due, probably, to that the current use of synthetic substrates for PON1 measurement limits the interpretation of the data. In the present study, we explored the relationships between the circulating levels of PON1 and MCP-1 in human immunodeficiency virus-infected patients in relation to the multifunctional capabilities of PON1. METHODS: We measured selected variables in 227 patients and in a control group of 409 participants. Serum PON1 esterase and lactonase activities were measured as the rates of hydrolysis of paraoxon and of 5-(thiobutyl)-butyrolactone, respectively. Oxidised LDL and MCP-1 concentrations were determined by enzyme-linked immunosorbent assay. High-density lipoproteins cholesterol, apolipoprotein A-I, and C-reactive protein concentrations were measured by standard automated methods. RESULTS: There were significant relationships between PON1 activity and several indices of oxidation and inflammation in control subjects and in infected patients. However, these relationships varied not only with disease status but also on the type of substrate used for PON1 measurement. CONCLUSION: The present study is a cautionary tale highlighting that results of clinical studies on PON1 may vary depending on the methods used as well as the disease studied. Until more specific methods using physiologically-akin substrates are developed for PON1 measurement, we suggest the simultaneous employment of at least two different substrates in order to improve the reliability of the results obtained.
Asunto(s)
Arildialquilfosfatasa/sangre , Infecciones por VIH/sangre , Proyectos de Investigación , Apolipoproteína A-I/biosíntesis , Proteína C-Reactiva/biosíntesis , Quimiocina CCL2/sangre , HDL-Colesterol/metabolismo , Técnicas de Laboratorio Clínico , Ensayo de Inmunoadsorción Enzimática/métodos , Humanos , Inflamación , Lactonas/sangre , Oxígeno/química , Paraoxon/sangreRESUMEN
Elevated plasma homocystein (Hcy) level has been recognized as an important risk factor for a number of cardiovascular diseases, peripheral arterial occlusive disease and venous thrombosis. A part of Hcy in the organism is turned to homocysteine thiolactone (HcyT) via a ring closure reaction, which gains rate in hyperhomocysteinemia, and in turn undergoes a hydrolytic reaction back to Hcy by paraoxonase enzyme (PON). Since this is a protective reflex action enzyme against hyperhomocysteinemia, we investigated how a mild hyperhomocysteinemic nutritional habit affected serum PON activity in a population-based study. The difference detected via enzymatic activity using the paraoxon substrate was statistically non-significant (p=0.19), suggesting a defective performance to reflect the expected significance. Determination of serum PON activity via substrate paraoxon yielded no significant difference in an acute mild hyperhomocysteinemic diet model in humans.
Asunto(s)
Arildialquilfosfatasa/sangre , Hiperhomocisteinemia/sangre , Hiperhomocisteinemia/diagnóstico , Paraoxon/sangre , Adolescente , Adulto , Biomarcadores/sangre , Activación Enzimática/fisiología , Femenino , Humanos , Masculino , Especificidad por Sustrato/fisiología , Encuestas y Cuestionarios , Adulto JovenRESUMEN
Human paraoxonase (PON1) plays a role in detoxification of organophosphorus (OP) compounds by hydrolyzing the bioactive oxons, and in reducing oxidative low-density lipoproteins, which may protect against atherosclerosis. Some PON1 polymorphisms have been found to be responsible for variations in catalytic activity and expression and have been associated with susceptibility to OP poisoning and vascular diseases. Both situations are of public health relevance in Mexico. Therefore, the aim of this study was to evaluate PON1 phenotype and the frequencies of polymorphisms PON1 -162, -108, 55, and 192 in a Mexican population. The studied population consisted of unrelated individuals (n = 214) of either gender, 18-52 years old. Serum PON1 activity was assayed using phenylacetate and paraoxon as substrates. PON1 variants, -162, 55, and 192, were determined by real-time PCR using the TaqMan System, and PON1 -108 genotype by PCR-RFLP. We found a wide interindividual variability of PON1 activity with a unimodal distribution; the range of enzymatic activity toward phenylacetate was 84.72 to 422.0 U/mL, and 88.37 to 1645.6 U/L toward paraoxon. All four PON1 polymorphisms showed strong linkage disequilibrium (D% >90). PON1 polymorphisms -108, 55, and 192 were independently associated with arylesterase activity; whereas the activity toward paraoxon was related only with PON1 192 polymorphism, suggesting that this polymorphism is determinant to infer PON1 activity. A better understanding of the phenotype and genotypes of PON1 in Mexican populations will facilitate further epidemiological studies involving PON1 variability in OP poisoning and in the development of atherosclerosis.
Asunto(s)
Arildialquilfosfatasa/genética , Arildialquilfosfatasa/metabolismo , Adulto , Alelos , Hidrolasas de Éster Carboxílico/genética , Hidrolasas de Éster Carboxílico/metabolismo , Femenino , Haplotipos , Humanos , Desequilibrio de Ligamiento/genética , Masculino , México/etnología , Persona de Mediana Edad , Paraoxon/sangre , Fenilacetatos/sangre , Polimorfismo Genético/genéticaRESUMEN
This work was performed to adapt the manual laboratory method of measuring serum paraoxonase activity using a routine automatized method in the clinical laboratory and to study the distribution of paraoxonase activity in a large population from Alcoy, a region of Spain. The serum samples for the study were obtained from extractions of blood from 2891 individuals, distributed by sex and age groups, in a routine check in a primary care facility of Alcoy. Paraoxonase activity was assayed by measuring the release of p-nitrophenol according to a previously published method adapted to an automatized analyzer. The mean paraoxonase activity recorder was 70.2 +/- 16.5 IU/L. Paraoxonase activity in children (both males and females) was significantly lower (p < 0.0005) than in older individuals. Paraoxonase activity detected in males and females older than 56 was slightly lower than that detected in younger individuals, although in this case the difference was not statistically significant. The paraoxonase activity shows higher mean values in females than in males (p < 0.0005). Human paraoxonase activity shows a unimodal distribution pattern in the studied population, which is in contrast with other studies showing bimodal distribution.
Asunto(s)
Arildialquilfosfatasa/sangre , Insecticidas/sangre , Paraoxon/sangre , Adolescente , Adulto , Autoanálisis , Femenino , Humanos , Hidrólisis , Masculino , Persona de Mediana Edad , Nitrofenoles/metabolismo , EspañaRESUMEN
The mortality rate of suicidal parathion poisoning is particularly high, the onset of fulminant cholinergic signs, and the patients frequently present to the emergency physician with life-threatening symptoms. Despite this uniformity, subsequent clinical course differs significantly among patients, mostly not as a result of different delays in treatment or insufficiency of primary care. Probably, the differences depend on the amount of poison absorbed and/or the disposition of the active poison, paraoxon. We followed the toxicokinetics of parathion and tried to quantify the actual poison load. To this end, we monitored parathion-intoxicated patients (patients requiring artificial ventilation) for plasma levels of parathion and paraoxon along with the activity of erythrocyte acetylcholinesterase and its reactivatability. Plasma obidoxime concentrations were followed as well as the cumulative urinary para-nitrophenol conjugate excretion as a measure of total poison load. All patients received a standard obidoxime scheme of a 250 mg bolus dose intravenously, followed by continuous infusion with 750 mg per 24 hours as long as reactivation could be expected (usually 1 week). All other treatment was instituted as judged by the physician. It was recommended to use atropine at low doses to achieve dry mucous membranes, no bronchoconstriction and no bradycardia. Usually 1-2 mg/h were sufficient. Seven selected cases are presented exemplifying toxicokinetic peculiarities. All patients were severely intoxicated, while the amount of parathion absorbed varied widely (between 0.12 and 4.4 g; lethal dose 0.02-0.1 g) and was generally much lower than anticipated from the reports of relatives. It remains open whether the discrepancies between reports and findings were due to exaggeration or to effective decontamination (including spontaneous vomiting, gastric lavage and activated charcoal). Absorption of parathion from the gastrointestinal tract was sometimes retarded, up to 5 days, resulting in fluctuating plasma profiles. The volume of distribution at steady-state (Vdss) of parathion was around 20 L/kg. Post-mortem analysis in one patient revealed a 66-fold higher parathion concentration in fat tissue compared with plasma, 16 days after ingestion. Biotransformation of parathion varied widely and was severely retarded in one patient receiving fluconazole during worsening of renal function, while phenobarbital (phenobarbitone) sedation (two cases) had apparently no effect. The proportion of plasma parathion to paraoxon varied from 0.3-30, pointing also to varying paraoxon elimination, as illustrated by one case with particularly low paraoxonase-1 activity. Obidoxime was effective at paraoxon concentrations below 0.5 microM, provided aging was not too advanced. This concentration correlated poorly with the paration concentration or the poison load. The data are discussed in light of the pertinent literature.
Asunto(s)
Inhibidores de la Colinesterasa , Reactivadores de la Colinesterasa/uso terapéutico , Colinesterasas/sangre , Cloruro de Obidoxima/uso terapéutico , Paratión , Absorción , Acetilcolinesterasa/sangre , Adulto , Anciano , Inhibidores de la Colinesterasa/metabolismo , Inhibidores de la Colinesterasa/farmacocinética , Inhibidores de la Colinesterasa/envenenamiento , Reactivadores de la Colinesterasa/sangre , Femenino , Semivida , Humanos , Persona de Mediana Edad , Mortalidad , Cloruro de Obidoxima/sangre , Paraoxon/sangre , Paratión/metabolismo , Paratión/farmacocinética , Paratión/envenenamiento , Intento de Suicidio , Distribución TisularRESUMEN
1. In vitro detoxification of the organophosphate (OP) insecticides paraoxon, chlorpyrifos-oxon and malaoxon has been investigated in human serum. 2. Specific A-esterase activity to each OP substrate was measured in the serum of 100 individuals using established spectrophotometric methods for paraoxonase and chlorpyrifos-oxonase and a novel assay for malaoxonase activity. 3. Dose-effect inhibition of serum cholinesterase by the three OPs was measured in pooled human serum. Inhibition of calcium dependent A-esterases by addition of EDTA resulted in increased inhibition of cholinesterase at a given OP concentration. 4. Data from both the direct spectrophotometric measurement of A-esterase activity and inhibition of serum cholinesterase in the presence and absence of A-esterase activity indicated that human serum A-esterase catalysed detoxification of chlorpyrifos-oxon> paraoxon> malaoxon. Our data also confirms the wide variation in potency to inhibit cholinesterase between the three OPs. 5. Malaoxonase activity in human serum does not appear to be polymorphic, however, there is large inter-individual variation as has been previously found for other A-esterases. 6. This study has demonstrated two approaches to investigate the inter-individual variation towards specific OPs and the relative ability of human serum A-esterase to detoxify specific OP compounds.
Asunto(s)
Hidrolasas de Éster Carboxílico/sangre , Insecticidas/farmacocinética , Insecticidas/toxicidad , Arildialquilfosfatasa , Hidrolasas de Éster Carboxílico/antagonistas & inhibidores , Cloropirifos/análogos & derivados , Cloropirifos/sangre , Cloropirifos/farmacocinética , Cloropirifos/toxicidad , Inhibidores de la Colinesterasa/farmacología , Relación Dosis-Respuesta a Droga , Esterasas/antagonistas & inhibidores , Esterasas/sangre , Humanos , Inactivación Metabólica , Insecticidas/sangre , Malatión/análogos & derivados , Malatión/sangre , Malatión/farmacocinética , Malatión/toxicidad , Paraoxon/sangre , Paraoxon/farmacocinética , Paraoxon/toxicidad , Especificidad por SustratoRESUMEN
Paraoxonase in serum and liver of rabbits and cattle was investigated. In serum the two substrates paraoxon and phenylacetate are exclusively hydrolyzed by alpha-lipoprotein-bound paraoxonase. In rabbit liver paraoxon is hydrolyzed only by paraoxonase, while phenylacetate is hydrolyzed by paraoxonase (20%) and additionally by an organophosphate sensitive carboxylesterase (B-Esterase), which is responsible for 80% of total liver phenylacetate hydrolysis. Phenyl acetate hydrolysis by B-Esterase of rabbit liver was shown to be inhibited by paraoxon and by mipafox covalently in a time and concentration dependent manner. Rabbit serum exhibits by far the highest serum paraoxonase activity (2.6 +/- 0.66 U/ml) of all vertebrate species tested up to now, while rabbit liver contains only 0.5 +/- 0.2 U/g fresh weight. In cattle extremely high paraoxonase activity is found in liver (2.8 U/g), while bovine serum contains only 0.2 U/g. The paraoxonase activity ratio (hydrolysis rate paraoxon: phenylacetate x 1000) in cattle does not show interindividual variation (activity ratio 4.0 +/- 0.4, correlation coefficient 0.996, P < 0.001). In contrast, the paraoxon/phenylacetate hydrolysis ratio of rabbit paraoxonase in serum as well as in liver does vary considerably between individuals. In cross-bred rabbits paraoxonase activity ratios from three to ten are found. In a strain of pure-bred New Zealand White rabbits three polymorphic serum paraoxonase phenotypes could be clearly differentiated by the activity ratio. By analogy with the human paraoxonase polymorphism, the rabbit paraoxonase isotypes were classified as paraoxonase A (activity ratio 3.8-4.3), AB (ratio 5.5-6.0) and B (ratio 7.3-8.6). The corresponding frequencies of the three isotypes were 40, 35 and 25%.
Asunto(s)
Esterasas/sangre , Esterasas/genética , Animales , Arildialquilfosfatasa , Carboxilesterasa , Hidrolasas de Éster Carboxílico/sangre , Hidrolasas de Éster Carboxílico/genética , Hidrolasas de Éster Carboxílico/metabolismo , Bovinos , Esterasas/metabolismo , Femenino , Humanos , Hidrólisis , Isoenzimas/sangre , Isoenzimas/genética , Isoenzimas/metabolismo , Cinética , Hígado/enzimología , Masculino , Paraoxon/sangre , Paraoxon/metabolismo , Fenilacetatos/metabolismo , Polimorfismo Genético , ConejosRESUMEN
The in vivo effects of the organophosphorus compound (OPC) paraoxon (POX) on blood coagulation of mini pigs were assessed by measuring the partial thromboplastin time (PTT), prothrombin time (PT), fibrinogen, factor V, factor VII, factor VIII, antithrombin III, protein C, and platelet count. The mini pigs were randomly assigned to a POX-treatment group (n = 9) receiving 54 mg POX kg(-1) BW(-1) or the control group (n = 9). Measurements were carried out over a period of 150 min after poisoning. The exposure to POX did not have any influence on measurements of PT, factor VIII, factor VII, factor V, antithrombin III, protein C, or fibrinogen compared to the control group evaluated by rank order test (ROT) during the time of observation (150 min). Changes seen in the intrinsic coagulation followed a biphasic pattern corresponding to an early sympathomimetic phase with PTT-shortening and a decrease of the platelet count, and a late vagal phase, with PTT-prolongation. The hypercoagulability seen in the sympathomimetic phase is probably due to a massive release of catecholamines from the adrenals. Previous studies showed in vitro no coagulation activating effect of POX. The hypocoagulability in the vagal phase shown by the PTT-protongation is probably due to POX influencing platelet function or its inhibition of clotting factors, which are serine proteases, or a combination of the two.
Asunto(s)
Coagulación Sanguínea/efectos de los fármacos , Inhibidores de la Colinesterasa/toxicidad , Paraoxon/toxicidad , Animales , Antitrombina III/análisis , Inhibidores de la Colinesterasa/sangre , Factor V/análisis , Factor VIII/análisis , Fibrinógeno/análisis , Inyecciones Intravenosas , Paraoxon/sangre , Tiempo de Tromboplastina Parcial , Recuento de Plaquetas/efectos de los fármacos , Proteína C/análisis , Tiempo de Protrombina , Porcinos , Porcinos EnanosRESUMEN
1. Paraoxon concentration was estimated by means of inhibition kinetics observed with electric eel acetylcholinesterase (AChE) which was determined by a modified Ellman procedure. In human plasma, paraoxon was stabilized by inactivation of paraoxonase with EDTA and aluminon and by inhibition of butyrylcholinesterase with ethopropazine. Paraoxon (1-50 ng) was recovered at 86+/-1.7% (mean+/-s.e.m.) in ether extracts from 0.5 ml samples of spiked stabilized plasma. It could be stored without loss at - 20 degrees C for at least 1 month. 2. The enzyme-based assay was applied to follow the paraoxon plasma concentrations in three suicidal patients with severe parathion poisoning. In poisoning with excessive doses and initial paraoxon concentrations above 500 nM, therapeutic obidoxime concentrations of approximately 10 microM failed to essentially reactivate erythrocyte AChE in vivo, while reactivatability ex vivo was nearly complete. With the plasma concentrations of paraoxon dropping below 100 nM, however, reactivation by obidoxime became significant. Unexpectedly, paraoxon levels occasionally reincreased during treatment and resulted in re-inhibition of AChE, bearing some resemblance to the Intermediate Syndrome. 3. The paraoxon concentrations measured fitted satisfactorily the values calculated from the kinetic constants previously obtained for AChE inhibition and obidoxime-induced reactivation in vitro. This indicates that diethylphosphoryloxime formation during obidoxime-induced reactivation does not markedly contribute to the re-inhibition of AChE as observed in vitro.
Asunto(s)
Inhibidores de la Colinesterasa/farmacología , Reactivadores de la Colinesterasa/farmacología , Esterasas/antagonistas & inhibidores , Paraoxon/sangre , Paratión/envenenamiento , Animales , Arildialquilfosfatasa , Ácido Aurintricarboxílico/farmacología , Estabilidad de Medicamentos , Ácido Edético/farmacología , Electrophorus/fisiología , Humanos , Técnicas In Vitro , Oximas/metabolismo , Oximas/farmacología , Parasimpatolíticos/farmacología , Fenotiazinas/farmacología , SuicidioRESUMEN
Trout were exposed to an aqueous solution of 75 ng/ml paraoxon for 5 days at 12 degrees C. The relationships among paraoxon concentration in water and target organs, AChE inhibition, and carboxylesterase (CaE) detoxification of paraoxon were characterized quantitatively by development of a PBPK-PD model. The PKPD model structure consisted of brain, heart, liver, kidney, and remainder of the body, which were interconnected by blood circulation. The paraoxon tissue/blood partition coefficients were: plasma/water, 1.46; liver/plasma, 5.89; brain/plasma, 3.90; heart/plasma, 2.91; kidney/plasma, 0.45; and blood/plasma, 0.91. Turnover of AChE was characterized from a dose-response study, in which its zero-order synthesis rate and first-order degradation rate constant were determined in several tissues; for brain they were 7.67 pmol/min and 7.31 x 10(-5) hr(-1). The uptake and depuration clearances of paraoxon (Cl(u) = 0.651 and Cl(d) = 0.468 ml min(-1) g body wt(-1)) were determined using a compartmental model. During continuous water exposure to paraoxon, AChE activity in the tissues declined to new steady state values that were maintained by the synthesis of new AChE. CaE was shown by simulation to be an important pathway for detoxification of paraoxon.
Asunto(s)
Inhibidores de la Colinesterasa/farmacocinética , Insecticidas/farmacocinética , Oncorhynchus mykiss/metabolismo , Paraoxon/farmacocinética , Acetilcolinesterasa/análisis , Acetilcolinesterasa/metabolismo , Animales , Encéfalo/efectos de los fármacos , Encéfalo/enzimología , Encéfalo/metabolismo , Carboxilesterasa , Hidrolasas de Éster Carboxílico/análisis , Hidrolasas de Éster Carboxílico/metabolismo , Inhibidores de la Colinesterasa/sangre , Inhibidores de la Colinesterasa/toxicidad , Cromatografía de Gases , Relación Dosis-Respuesta a Droga , Femenino , Branquias/metabolismo , Corazón/efectos de los fármacos , Insecticidas/sangre , Insecticidas/toxicidad , Riñón/efectos de los fármacos , Riñón/enzimología , Riñón/metabolismo , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/metabolismo , Masculino , Modelos Biológicos , Miocardio/enzimología , Miocardio/metabolismo , Paraoxon/sangre , Paraoxon/toxicidad , Control de Calidad , Distribución Tisular , Contaminantes Químicos del Agua/metabolismo , Contaminantes Químicos del Agua/toxicidadRESUMEN
A sensitive capillary gas chromatographic (GC) method for the simultaneous determination of the organophosphate insecticide, parathion, and its active metabolite, paraoxon, in biological samples was developed. This method involved a simple liquid-liquid extraction of parathion and paraoxon from water, plasma, or tissues and capillary GC determination using electron-capture detection and splitless injection; malathion was used as the internal standard. A gradient oven temperature program was used; the injection port and detector temperatures were 200 and 300 degrees C, respectively. These techniques allowed quantitative determination of parathion and paraoxon at 9-210-ng/ml. concentrations;recoveries ranged from 79.4 to 110.3% for tissues and from 91.9 to 100.0% for plasma and water. The within-day and between-day coefficients of variation were less than 8.0%. The method was used to characterize the pharmacokinetics of parathion and paraoxon and the tissue distribution of paraoxon in rainbow trout.
Asunto(s)
Insecticidas/análisis , Paraoxon/análisis , Paratión/análisis , Animales , Química Encefálica , Cromatografía de Gases , Insecticidas/sangre , Riñón/química , Malatión/sangre , Malatión/metabolismo , Músculos/química , Miocardio/química , Oncorhynchus mykiss , Paraoxon/sangre , Paratión/sangre , Estándares de Referencia , Reproducibilidad de los Resultados , Distribución TisularRESUMEN
The mammalian detoxification of certain organophosphates, such as paraoxon [O,O-diethyl (p-nitrophenyl) phosphate], is catalyzed by the enzyme A-esterase. In this study, incubations of human serum in 50 mM glycine buffer (pH 10.5) with paraoxon resulted in the nonlinear production of p-nitrophenol, characterized by a rapid initial phase for the first several minutes of the incubation, followed by a second, slower phase in which the velocity approached constancy. Production of p-nitrophenol could be accurately fitted to the velocity equation for an Ordered Uni Bi kinetic mechanism with initial-burst activity, yielding estimates of appk2, appk3, and appE, for 10 human subjects. Increasing calcium concentration in the incubation resulted in increases in appk3 and appE, without affecting appk2. Conversely, addition of 1 M sodium chloride decreased the appk3 and appE, but did not alter appk2. And finally, a continuous system computer model was constructed based on the differential equations descriptive of an Ordered Uni Bi kinetic mechanism. This model accurately simulated production of p-nitrophenol from human serum, providing further support that A-esterase hydrolyzes paraoxon by an Ordered Uni Bi kinetic mechanism with initial-burst activity.
Asunto(s)
Hidrolasas de Éster Carboxílico/sangre , Esterasas/sangre , Paraoxon/farmacocinética , Adulto , Arildialquilfosfatasa , Tampones (Química) , Simulación por Computador , Femenino , Humanos , Hidrólisis , Inactivación Metabólica , Cinética , Masculino , Persona de Mediana Edad , Modelos Biológicos , Nitrofenoles/sangre , Nitrofenoles/metabolismo , Paraoxon/sangre , Paraoxon/metabolismoRESUMEN
The heat inactivation of esterases in human and rabbit serum was followed at 50 and 55 degrees C by measuring the decrease of activity with paraoxon, phenylacetate and beta-naphthylacetate as substrates. The rate of inactivation measured with the three substrates was slightly, but significantly different, indicating that the substrates are hydrolysed by different enzymes.
Asunto(s)
Hidrolasas de Éster Carboxílico/sangre , Monoéster Fosfórico Hidrolasas/sangre , Animales , Arildialquilfosfatasa , Interacciones Farmacológicas , Activación Enzimática , Estabilidad de Enzimas , Calor , Humanos , Hidrólisis , Cinética , Ácidos Naftalenoacéticos/sangre , Paraoxon/sangre , Fenilacetatos/sangre , ConejosRESUMEN
The hydrolysis of four organophosphorus dichlorophenyl esters and of paraoxon was studied in hen brain homogenates and in rabbit serum. All compounds were hydrolysed by both preparations, but the rates were different in the two preparations. EDTA inhibited the hydrolysis almost completely in rabbit serum, but had only a small effect on the hydrolysis in hen brain homogenates.
Asunto(s)
Encéfalo/enzimología , Oxigenasas de Función Mixta/metabolismo , Compuestos Organofosforados/metabolismo , Paraoxon/metabolismo , Animales , Arildialquilfosfatasa , Hidrolasas de Éster Carboxílico/sangre , Hidrolasas de Éster Carboxílico/metabolismo , Pollos , Femenino , Hidrólisis , Cinética , Oxigenasas de Función Mixta/sangre , Compuestos Organofosforados/sangre , Paraoxon/sangre , Monoéster Fosfórico Hidrolasas/sangre , Monoéster Fosfórico Hidrolasas/metabolismo , Conejos , Especificidad por SustratoRESUMEN
A new approach is described for studying the polymorphism of paraoxon hydrolyzing serum esterases after isoelectric focusing of native sera. Enzyme visualization is performed by a modified sandwich procedure which is faster and also affords higher resolution and considerably improved sensitivity. Up to seven paraoxon splitting isoenzymes can be visualized and clearly distinguished from arylesterases and phosphatases by using 3-naphtyl acetate, paraoxon, 5-bromo-4-chloro-3-indolyl acetate and 5-bromo-4-chloro-3-indolyl phosphate as substrates. The new technique is also able to differentiate between paraoxonase isoenzymes sensitive to EDTA and those which are EDTA-stable. Immunofixation with anti-human serum albumin-antibodies revealed similar isoelectric points for these isoenzymes, although they are not assumed to be identical. The new technique may prove useful in other applications of enzyme visualization where diffusion of enzymes and/or cleavage products is the major problem.
Asunto(s)
Focalización Isoeléctrica , Isoenzimas/sangre , Paraoxon/sangre , Monoéster Fosfórico Hidrolasas/sangre , Sefarosa , Arildialquilfosfatasa , Humanos , Hidrólisis , Naftoles/metabolismo , Fenilacetatos/metabolismo , Monoéster Fosfórico Hidrolasas/genética , Polimorfismo Genético , Sensibilidad y Especificidad , Albúmina SéricaRESUMEN
The activity of paraoxonase in serum was found to be bimodally distributed, both in a control group and in a group of patients who had suffered myocardial infarction. Activity in the myocardial infarct group was significantly lower than in the control group. Low paraoxonase activity in serum may provide an indication of susceptibility to the development of coronary heart disease.